Drug Safety Settlement
Daiichi Sankyo says it was misled over Ranbaxy U.S. probes
Japanese drugmaker Daiichi Sankyo Co, which bought control of Ranbaxy Laboratories in 2008, said it believes unnamed former shareholders of the company hid information regarding U.S. regulatory probes into Ranbaxy. Full Article
- Gold slips after Bernanke hints at slowing bond buys
- FBI says man shot dead while being questioned about Boston bombings
- British soldier hacked to death in suspected Islamist attack
- Soldier hacked to death in London in suspected Islamist attack
- Short story writer Lydia Davis wins Man Booker International fiction prize
REUTERS SHOWCASE
Tax Avoidance
EU leaders talk tough on tackling Amazon, Google over taxes. Full Article | Related Story
Buy, Sell or Hold?
Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade. Full Coverage
Reuters India Mobile
Get the latest news on the go. Visit Reuters India on your mobile device. Full Coverage
Hindustan Copper share sale price fixed at 155 rupees/share - sources
MUMBAI |
MUMBAI (Reuters) - The base price for sale of the government's 4 percent stake in state-run Hindustan Copper Ltd(HCPR.NS) has been fixed at 155 rupees a share, two sources with direct knowledge of the matter said on Thursday.
The share sale, to be launched on Friday, will raise 5.74 billion rupees at the floor price. Shares in Hindustan Copper ended 11.3 percent higher on Thursday at 266.15 rupees.
The government, which owns 99.6 percent of Hindustan Copper, said on Wednesday it would sell a 4 percent stake in the company through auction of shares.
The government aims to raise 300 billion rupees through share sales in state-run companies in the current fiscal year that ends in March, but has thus far drawn a blank as weak market conditions have deterred public issues or auctions. (Reporting by Sumeet Chatterjee; Editing by Prateek Chatterjee)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints






Follow Reuters